The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade

• Camille Bonomelli ,

  Contributed equally to this work with: Camille Bonomelli, Katie J. Doores

  Affiliation Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom

  ⨯
• Katie J. Doores ,

  Contributed equally to this work with: Camille Bonomelli, Katie J. Doores

  Affiliations Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America, Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America

  ⨯
• D. Cameron Dunlop,

  Affiliation Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America

  ⨯
• Victoria Thaney,

  Affiliation Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America

  ⨯
• Raymond A. Dwek,

  Affiliation Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom

  ⨯
• Dennis R. Burton,

  Affiliations Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America, Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America

  ⨯
• Max Crispin,

  Affiliation Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom

  ⨯
• Christopher N. Scanlan

  * E-mail: chris.scanlan@bioch.ox.ac.uk

  Affiliation Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, United Kingdom

  ⨯